Essex Woodlands Management, Inc. Long-Term Concentrated

Location: The Woodlands, TX

CIK: 0001542339 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 15, 2023

Total Value: $173M (100.0% shares, 0.0% debt)

Holdings (7)

MDXG MIMEDX GROUP, INC. 46.2%

Value $79.85M Shares 23,415,584 Est. Cost $7.34 Unrealized -47.3%

TELA TELA BIO, INC. 25.3%

Value $43.74M Shares 4,110,709 Est. Cost $11.82 Unrealized -6.6%

— REVANCE THERAPEUTICS INC 8.5%

Value $14.72M Shares 457,085 Est. Cost $31.50 Unrealized —

BVS BIOVENTUS 7.5%

Value $12.94M Shares 12,096,702 Est. Cost $14.24 Unrealized -86.6%

EYPT EYEPOINT PHARMACEUTICALS INC 7.1%

Value $12.32M Shares 4,190,921 Est. Cost $4.68 Unrealized -23.8%

— VENUS CONCEPT, INC. 4.0%

Value $6.863M Shares 31,337,856 Est. Cost $2.12 Unrealized —

MNOV MEDICINOVA INC 1.4%

Value $2.389M Shares 1,105,941 Est. Cost $2.95 Unrealized -22.3%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
MDXG	MIMEDX GROUP, INC.	23,415,584	$79.85M	46.2%	$7.34	-47.3%	COM	602496101
TELA	TELA BIO, INC.	4,110,709	$43.74M	25.3%	$11.82	-6.6%	COM	872381108
—	REVANCE THERAPEUTICS INC	457,085	$14.72M	8.5%	$31.50	—	COM	761330109
BVS	BIOVENTUS	12,096,702	$12.94M	7.5%	$14.24	-86.6%	COM CL A	09075A108
EYPT	EYEPOINT PHARMACEUTICALS INC	4,190,921	$12.32M	7.1%	$4.68	-23.8%	COM NEW	30233G209
—	VENUS CONCEPT, INC.	31,337,856	$6.863M	4.0%	$2.12	—	COM	92332W105
MNOV	MEDICINOVA INC	1,105,941	$2.389M	1.4%	$2.95	-22.3%	COM NEW	58468P206